Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Curtis Lockshin is Director at Phio Pharmaceuticals. OQRO lists 1 transaction filed with the SEC under this name, the latest on Feb 6, 2026, each linked to the official Form 4.
Director
Disclosures on record
1
Companies involved
1
As of the latest filing on , Curtis Lockshin reported holding 35,155 shares of Phio Pharmaceuticals (PHIO), worth about $27K at the last close of $1 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Phio Pharmaceuticals PHIO | 35,155 | 35K direct | $1 | $27K | Feb 5, 2026 |
Is this Curtis Lockshin’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Curtis Lockshin bought shares on the open market in 2013, and has not bought since 2013.
Curtis Lockshin reported 1 open-market purchase and 0 sales since 2013; purchases in 2013.
| Year | Bought | Sold |
|---|---|---|
| 2013 | $3.7K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Feb 5, 202617Kdisclosed Feb 6
DetailsOfficial recordCurtis Lockshin reported 1 open-market purchase and 0 sales here, 2013.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Feb 5, 2026, Curtis Lockshin reported holding 35,155 shares of Phio Pharmaceuticals (PHIO). At the last close of $1 on Nov 13, 2026, that is about $27K. This is the stake disclosed in filings, not a net worth.
Curtis Lockshin bought shares on the open market in 2013, and has not bought since 2013.
In SEC filings since 2013: the latest open-market purchase is from 2013; no open-market sale is on record.
Phio Pharmaceuticals (PHIO), from 2013 to 2013: 1 purchase and 0 sales.